Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alberto Cruz-Bermúdez"'
Autor:
Aránzazu García-Grande, María José Coronado, Clara Salas, Sara Laine-Menéndez, José Miguel García, Raquel Laza-Briviesca, Ramiro J. Vicente-Blanco, Paloma Martín-Acosta, Fernando Franco, Alberto Cruz-Bermúdez, Atocha Romero, Mariano Provencio, Juan Cristobal Sanchez, Cristina Alfaro, Virginia Calvo
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
instname
Lung cancer is a major public health problem due to its high incidence and mortality rate. The altered metabolism in lung cancer is key for the diagnosis and has implications on both, the prognosis and the response to treatments. Although Cancer-asso
Publikováno v:
Journal of Thoracic Oncology. 16:S70-S71
Autor:
Belén Sierra-Rodero, B. Massuti, E. Del Barco, G. Lopez Vivanco, Santiago Viteri, M. Casarrubios, G. Huidobro, M.R. Garcia Campelo, Isidoro Barneto, E. Nadal, Margarita Majem, R. Laza Briviesca, A. Insa, Nuria Viñolas, Alberto Cruz-Bermúdez, J. De Castro Campeño, M. Domine Gomez, R. Bernabe Caro, Alex Martinez-Marti, M. Provencio, Delvys Rodriguez-Abreu, M. Cobo Dols
Publikováno v:
Journal of Thoracic Oncology. 16:S220-S221
Autor:
Santiago Viteri, G. López Vivanco, M. Jove, J. Casal, M. Majem Tarruella, R. Bernabe Caro, Alex Martinez-Marti, Belén Sierra-Rodero, R. Laza Briviesca, Nuria Viñolas, J. De Castro Campeño, Alberto Cruz-Bermúdez, A. Insa, M. Casarrubios, M.R. Garcia Campelo, M. Provencio, F. Franco, M. Cobo Dols, B. Massuti, Manuel Domine, E. Del Barco, Ernest Nadal, Delvys Rodriguez-Abreu, Isidoro Barneto
Publikováno v:
Journal of Thoracic Oncology. 16:S545-S546
Autor:
E. García-Veros, Roberto Serna-Blasco, Alberto Cruz-Bermúdez, V. Calvo, M. Casarrubios, M. Provencio, Belén Sierra-Rodero, A. Romero, Alfredo Sanchez-Hernandez, Estela Sánchez-Herrero, Raquel Laza-Briviesca, A. Rodriguez-Festa, X. Mielgo-Rubio, E.A. Uribelarrea, Sandra Sanz-Moreno
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
ESMO Open
instname
ESMO Open
Background: KRAS is mutated in ∼30% of non-small-cell lung cancer (NSCLC) but it has also been identified as one of the mechanisms underlying resistance to tyrosine kinase inhibitors (TKIs) in EGFR-positive NSCLC patients. Novel KRAS inhibitors tar
Autor:
Alberto Cruz-Bermúdez, Alex Martinez-Marti, J. De Castro Carpeno, M. Casarrubios, D. Rodriguez Abreu, Raquel Laza-Briviesca, Nuria Viñolas, A. Insa, I.C. Barneto Aranda, J. Casal Rubio, M. Martínez-Cutillas, Belén Sierra-Rodero, M.R. Garcia Campelo, M. Domine Gomez, M. Provencio, B. Massuti Sureda, M. Majem Tarruella, Ernest Nadal, E. Del Barco, Y. Garitaonaindia
Publikováno v:
Journal of Thoracic Oncology. 16:S740
Autor:
M. Jove, J. Mosquera, R. Bernabe Caro, Alex Martinez-Marti, Delvys Rodriguez-Abreu, Alberto Cruz-Bermúdez, F. Franco, Alejandro Romero, M. Cobo Dols, Nuria Viñolas, R. Laza Briviesca, Ernest Nadal, M. Majem Tarruella, B. Massuti, A. Insa, E. Del Barco, M. Casarrubios, M. Provencio, Santiago Viteri, G. López Vivanco, J. De Castro Campeño, M. Domine Gomez, G. Huidobro, Isidoro Barneto
Publikováno v:
Journal of Thoracic Oncology. 16:S543
Autor:
Nuria Viñolas, M. Casarrubios, Alberto Cruz-Bermúdez, E. Nadal, Guillermo Lopez-Vivanco, E. Del Barco, M. Cobo, Delvys Rodriguez-Abreu, M. Provencio, Bartomeu Massuti, A. Insa, Isidoro Barneto, Manuel Domine, N. De Dios Alvarez, R. Bernabé, V. Calvo De Juan, R. Garcia Campelo, Raquel Laza-Briviesca, Margarita Majem, Santiago Viteri, Alex Martinez-Marti, J. De Castro Carpeno
Publikováno v:
Journal of Thoracic Oncology. 14:S711
Autor:
D. Rodriguez Abreu, G. Huidobro, M. Majem Tarruella, I.C. Barneto Aranda, B. Massuti Sureda, E. Nadal, E. del Barco Morillo, G. López Vivanco, M. Provencio, Alex Martinez-Marti, JCastro De Carpeno, M.-R. García-Campelo, Alberto Cruz-Bermúdez, R. Bernabé, M. Domine Gomez, Raquel Laza-Briviesca, M. Casarrubios, M. Cobo Dols, M A Insa Molla, Nuria Viñolas
Publikováno v:
Annals of Oncology. 30:v507
Background Immunotherapy has become the main therapy in advanced NSCLC patients, but recently, combination with chemotherapy in locally advanced stages is showing promising results. Many studies have described peripheral blood immune cells parameters
Autor:
José-Vicente García, María Mercedes Soriano, C. Alfaro Autor, Ana Royuela, R. Gómez Bravo, Mariano Provencio, M. Mendez Garcia, V. Calvo De Juan, Alberto Cruz-Bermúdez, Fábio Gazelato de Mello Franco
Publikováno v:
Annals of Oncology. 30:v594
Background PET/CT is an essential component in the initial assessment of locally advanced NSCLC. However, the role of PET/CT in the assessment of response to therapies is not well established. Methods We reviewed all stage III NSCLC patients assessed